Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IceCure Medical (ICCM) Capital Expenditures (2020 - 2025)

Historic Capital Expenditures for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to -$3000.0.

  • IceCure Medical's Capital Expenditures rose 9062.5% to -$3000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$36000.0, marking a year-over-year increase of 7551.02%. This contributed to the annual value of -$71000.0 for FY2024, which is 8520.83% up from last year.
  • Latest data reveals that IceCure Medical reported Capital Expenditures of -$3000.0 as of Q3 2025, which was up 9062.5% from -$22000.0 recorded in Q2 2025.
  • Over the past 5 years, IceCure Medical's Capital Expenditures peaked at $1.7 million during Q4 2022, and registered a low of -$349000.0 during Q2 2022.
  • In the last 5 years, IceCure Medical's Capital Expenditures had a median value of -$69000.0 in 2021 and averaged $44315.8.
  • Per our database at Business Quant, IceCure Medical's Capital Expenditures surged by 13246.07% in 2021 and then tumbled by 26666.67% in 2025.
  • Quarter analysis of 5 years shows IceCure Medical's Capital Expenditures stood at $888000.0 in 2021, then soared by 89.41% to $1.7 million in 2022, then plummeted by 104.82% to -$81000.0 in 2023, then surged by 93.83% to -$5000.0 in 2024, then surged by 40.0% to -$3000.0 in 2025.
  • Its last three reported values are -$3000.0 in Q3 2025, -$22000.0 for Q2 2025, and -$6000.0 during Q1 2025.